Evidence map›Paper›PMID 25658584›Full record

ArticlePloS one2015

Autoregulation and heterogeneity in expression of human Cripto-1.

Pojul Loying, Janvie Manhas, Sudip Sen, Biplab Bose

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pojul LoyingDepartment of Biotechnology, Indian Institute of Technology Guwahati, Guwahati, India.
Janvie ManhasDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Sudip SenDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Biplab BoseDepartment of Biotechnology, Indian Institute of Technology Guwahati, Guwahati, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cripto-1 (CR-1) is involved in various processes in embryonic development and cancer. Multiple pathways regulate CR-1 expression. Our present work demonstrates a possible positive feedback circuit where CR-1 induces its own expression. Using U-87 MG cells treated with exogenous CR-1, we show that such induction involves ALK4/SMAD2/3 pathway. Stochasticity in gene expression gives rise to heterogeneity in expression in genetically identical cells. Positive feedback increases such heterogeneity and often gives rise to two subpopulations of cells, having higher and lower expression of a gene. Using flow cytometry, we show that U-87 MG cells have a minuscule subpopulation with detectable expression of CR-1. Induction of CR-1 expression, by exogenous CR-1, increases the size of this CR-1 positive subpopulation. However, even at very high dose, most of the cells remain CR-1 negative. We show that population behavior of CR-1 induction has a signature similar to bimodal expression expected in a transcriptional circuit with positive feedback. We further show that treatment of U-87 MG cells with CR-1 leads to higher expression of drug efflux protein MDR-1 in the CR-1 positive subpopulation, indicating correlated induction of these two proteins. Positive feedback driven heterogeneity in expression of CR-1 may play crucial role in phenotypic diversification of cancer cells.

Indexed as

Activin Receptors, Type IAnalysis of VarianceATP Binding Cassette Transporter, Subfamily BBlotting, WesternCell Line, TumorFeedback, PhysiologicalFlow CytometryGene Expression RegulationGPI-Linked ProteinsHomeostasisHumansIntercellular Signaling Peptides and ProteinsNeoplasm ProteinsSignal TransductionSmad2 ProteinSmad3 ProteinABCB1 protein, humanActivin Receptors, Type IACVR1B protein, humanATP Binding Cassette Transporter, Subfamily BGPI-Linked ProteinsIntercellular Signaling Peptides and ProteinsNeoplasm ProteinsSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTDGF1 protein, human

Identifiers

PMID25658584
PMCPMC4319928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.